SCHEMBL6037276

SCHEMBL6037276

O=C1C=CC(=O)N1.O=P(O)(O)CCCCCCCCCCCO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
CCR6 P51684 1/20 0.41
LPAR3 Q9UBY5 3/20 0.41
LPAR2 Q9HBW0 1/20 0.41
TYMS P04818 1/20 0.39
TYMP P19971 2/20 0.36
PNP P00491 6/20 0.35
HPRT1 P00492 4/20 0.35
LMNA P02545 1/20 0.34
CYP3A4 P08684 1/20 0.34
NFKB1 P19838 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,4-Butanediol SCHEMBL28150883 0.82 GSK3A (0.61) GSK3AGSK3BCCR6LMNACYP3A4
SCHEMBL4534488 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4531101 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4524151 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4528296 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4535194 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4527268 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4534884 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4528038 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4
SCHEMBL4533375 0.79 TYMS (0.61) LPAR3LPAR2TYMSLMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060194008-A1 Devices with multiple surface functionality PRINCETON UNIVERSITY (US) 2006-08-31 US disclosed